×
Back to Agenda
Session 11: Benefit-Risk Assessment
Session Chair(s)
James Buchanan, PharmD
President
Covilance LLC, United States
- PROTECT
- FDA Framework
- EMA Framework
- CIOMS Working Group XII
- DIA / ASA Biopharm Working Group - Benefit/Risk Assessment Plan/Tool
Have an account?